{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:08:32Z","timestamp":1753891712041,"version":"3.41.2"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Paraneoplastic lower motor neuronopathies (LMNs) have rarely been reported with malignant liver tumors. A 71-year-old man developed chronic progressive upper limb and cranial nerve paralysis. Electromyography examination suggests chronic progressive neuronal damage involving the right C4\u2013T1 nerve root innervated muscle and the right sternocleidomastoid muscle. Magnetic resonance imaging suggested the presence of a malignant liver tumor. His serum was positive for anti-Yo antibodies. Hepatic artery chemoembolization was performed, followed by treatment with pembrolizumab and lenvatinib. The patient\u2019s condition improved, and paraneoplastic LMNs were diagnosed. Paraneoplastic causes should be considered in the differential diagnosis of chronic progressive LMNs. A combination of surgical treatment and immunotherapy may result in a favorable outcome.<\/jats:p>","DOI":"10.3389\/fneur.2024.1325318","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T04:46:21Z","timestamp":1707713181000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case report: Paraneoplastic lower motor neuronopathy associated with a malignant liver tumor"],"prefix":"10.3389","volume":"15","author":[{"given":"Chaowei","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanfan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.neurol.2018.04.016","article-title":"Atypical motor neuron disease variants: still a diagnostic challenge in neurology","volume":"175","author":"Pinto","year":"2019","journal-title":"Rev Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e1014","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jns.2015.08.014","article-title":"Paraneoplastic subacute lower motor neuron syndrome associated with solid cancer","volume":"358","author":"Verschueren","year":"2015","journal-title":"J Neurol Sci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1007\/s00415-018-8881-0","article-title":"Motor neuron disease of paraneoplastic origin: a rare but treatable condition","volume":"265","author":"M\u00e9l\u00e9","year":"2018","journal-title":"J Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jneuroim.2015.11.016","article-title":"Intrathecal synthesis of onconeural antibodies in patients with paraneoplastic syndromes","volume":"290","author":"Corsini","year":"2016","journal-title":"J Neuroimmunol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/B978-0-444-52902-2.00041-2","article-title":"Paraneoplastic neuropathy","volume":"115","author":"Koike","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jns.2013.11.025","article-title":"Association of a paraneoplastic motor neuron disease with anti-Ri antibodies and a novel SOD1 I18del mutation","volume":"337","author":"Diard-Detoeuf","year":"2014","journal-title":"J Neurol Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.neurol.2017.03.018","article-title":"Motor neuropathies and lower motor neuron syndromes","volume":"173","author":"Verschueren","year":"2017","journal-title":"Rev Neurol (Paris)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1136\/jnnp-2016-313526","article-title":"Differentiating lower motor neuron syndromes","volume":"88","author":"Garg","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1136\/jnnp.2008.159483","article-title":"Cerebrospinal fluid study in paraneoplastic syndromes","volume":"81","author":"Psimaras","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e0123446","DOI":"10.1371\/journal.pone.0123446","article-title":"Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers","volume":"10","author":"Greenlee","year":"2015","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/1531-8249(20010201)49:2<253::aid-ana47>3.0.co;2-3","article-title":"Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus","volume":"49","author":"Sutton","year":"2001","journal-title":"Ann Neurol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3109\/21678421.2014.965178","article-title":"Is there a paraneoplastic ALS?","volume":"16","author":"Corcia","year":"2015","journal-title":"Amyotroph Later Scler Frontotemporal Degener"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1325318\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T04:46:24Z","timestamp":1707713184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1325318\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,12]]},"references-count":13,"alternative-id":["10.3389\/fneur.2024.1325318"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1325318","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2024,2,12]]},"article-number":"1325318"}}